84 related articles for article (PubMed ID: 5235902)
1. Chlorpromazine ocular toxicity.
Johnson AW
N C Med J; 1967 Nov; 28(11):474-6. PubMed ID: 5235902
[No Abstract] [Full Text] [Related]
2. Asymmetric anterior segment changes induced by chlorpromazine.
Deluise VP; Flynn JT
Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636
[TBL] [Abstract][Full Text] [Related]
3. [Ocular complications in long-term chlorpromazine treatment].
Klíma M; Klímová A
Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908
[No Abstract] [Full Text] [Related]
4. Ocular complications related to phenothiazines.
Siddall JR
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
[No Abstract] [Full Text] [Related]
5. Ocular toxicity of systemic drugs. A review of the effects of seven commonly used agents.
Davidorf FH
Ohio State Med J; 1972 Nov; 68(11):1022-6. PubMed ID: 5079160
[No Abstract] [Full Text] [Related]
6. Chlorpromazine.
Macri F
Eye Ear Nose Throat Mon; 1971 Mar; 50(3):111-2. PubMed ID: 5552871
[No Abstract] [Full Text] [Related]
7. Ocular complications of systemic medications.
Ellis PP
Tex Med; 1971 Apr; 67(4):70-3. PubMed ID: 5552586
[No Abstract] [Full Text] [Related]
8. Cutaneous and ocular changes associated with the use of chlorpromazine.
Wolf ME; Richer S; Berk MA; Mosnaim AD
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
[TBL] [Abstract][Full Text] [Related]
9. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
Gombos GM; Yarden PE
Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
[No Abstract] [Full Text] [Related]
10. [Ophthalmologic manifestations, with or without associated skin disorders, during prolonged treatment with chlorpromazine].
Baron JB; Morel P; Rivoallan Y; Soulairac A
Agressologie; 1968; 9(2):293-304. PubMed ID: 5675496
[No Abstract] [Full Text] [Related]
11. Incidence and significance of chlorpromazine-induced eye changes.
De Long SL
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
[No Abstract] [Full Text] [Related]
12. Ocular melanosis with special reference to chlorpromazine.
Cameron ME
Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771
[No Abstract] [Full Text] [Related]
13. Ocular changes associated with long term phenothiazine usage.
Alexander TA; John JK; Thomas A; Verghese A
Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036
[No Abstract] [Full Text] [Related]
14. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
[No Abstract] [Full Text] [Related]
15. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
Prien RF; DeLong SL; Cole JO; Levine J
Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
[No Abstract] [Full Text] [Related]
16. [Complications involving the eye caused by psychotrophic drugs].
Gol'dovskaia IL
Vestn Oftalmol; 1970; 6():54-7. PubMed ID: 5510856
[No Abstract] [Full Text] [Related]
17. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
18. Chlorpromazine-induced anterior segment changes.
Brooks JG; Matoba AY
Arch Ophthalmol; 1992 Jan; 110(1):126. PubMed ID: 1731707
[No Abstract] [Full Text] [Related]
19. [Ocular changes in long-term treatment with Largactil].
Kalberer M; Atar Z; Bider E
Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755
[No Abstract] [Full Text] [Related]
20. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy.
Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO
Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
